Brain
Psychedelics are helping dying patients overcome their existential distress
End of life patients face existential and spiritual challenges other patients do not. Psychedelics may be uniquely suited to helping them.
First: Spinal cord stimulation helps stroke survivors control arms again
Spinal cord stimulation has been shown to improve upper-limb mobility in stroke survivors for the first time.
DMT therapy appears effective for depression in phase 2 clinical trial
London-based Small Pharma has released positive top-line results for their phase 2a trial of DMT as an antidepressant.
Human-rat brain hybrid shows a way to cure blindness
New research has shown that human “mini brains” can integrate with damaged rat brains to perform functions related to sight.
New brain implant breaks record for turning thoughts into text
Stanford researchers have developed a brain-computer interface that allowed a woman to “type” 62 words per minute using only her thoughts.
New biomarker test accurately predicts who will respond to antidepressant
Alto Neuroscience’s depression drug seems effective in early trials, a proof-of-concept for biomarker-based design.
Brain experiment suggests that consciousness relies on quantum entanglement
Researchers possibly witnessed entanglement in the brain, indicating that some brain activity, like consciousness, operates on a quantum level.
New brain cancer treatment trialed in children for the first time
MRI-guided focused ultrasound has been used to deliver chemo into the brain of a pediatric cancer patient for the first time.
“Jumping genes”: A new model of Alzheimer’s
A new hypothesis suggests that Alzheimer's disease is the result of "jumping genes" in the brain, not inflammation or plaque.
FDA approves new Alzheimer’s medication
Lecanemab, a new Alzheimer’s medication shown to slow cognitive decline in patients, has been granted accelerated approval by the FDA.